INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $22,000 | +10.0% | 6,000 | +20.0% | 0.01% | -12.5% |
Q4 2018 | $20,000 | -28.6% | 5,000 | 0.0% | 0.01% | -27.3% |
Q3 2018 | $28,000 | +600.0% | 5,000 | +400.0% | 0.01% | +450.0% |
Q2 2018 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,000 | -37.5% | 1,000 | -20.0% | 0.00% | -50.0% |
Q3 2017 | $8,000 | -42.9% | 1,250 | -28.6% | 0.00% | -50.0% |
Q2 2017 | $14,000 | +180.0% | 1,750 | +133.3% | 0.01% | +166.7% |
Q1 2017 | $5,000 | 0.0% | 750 | 0.0% | 0.00% | +50.0% |
Q4 2016 | $5,000 | -28.6% | 750 | 0.0% | 0.00% | -60.0% |
Q3 2016 | $7,000 | -12.5% | 750 | 0.0% | 0.01% | -16.7% |
Q2 2016 | $8,000 | +14.3% | 750 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $7,000 | +16.7% | 750 | 0.0% | 0.01% | +25.0% |
Q4 2015 | $6,000 | +20.0% | 750 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $5,000 | -28.6% | 750 | 0.0% | 0.00% | -20.0% |
Q2 2015 | $7,000 | +16.7% | 750 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $6,000 | -14.3% | 750 | 0.0% | 0.01% | -28.6% |
Q4 2014 | $7,000 | – | 750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |